Indication
Mydriasis during ocular surgery
Mydriasis during ocular surgery refers to the pharmacologically induced and maintained dilation of the pupil within the ophthalmic system during intraocular procedures, most notably cataract extraction and intraocular lens replacement. Read more about Mydriasis during ocular surgery
8 drugs 8 manufacturers
Drugs that treat it
Common Mydriasis during ocular surgery therapies.
EPINEPHRINE (epinephrine HCl/PF)
OMIDRIA (phenylephrine HCl/ketorolac tromethamine)
OMIDRIA (phenylephrine HCl/ketorolac tromethamine)
OMIDRIA (phenylephrine HCl/ketorolac tromethamine)
EPINEPHRINE CONVENIENCE KIT (epinephrine)
EPINEPHRINE
ADRENALIN (epinephrine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMydriasis during ocular surgery refers to the pharmacologically induced and maintained dilation of the pupil within the ophthalmic system during intraocular procedures, most notably cataract extraction and intraocular lens replacement.
This clinical state involves stimulating the iris dilator muscle, inhibiting the pupillary sphincter muscle, or blunting surgically triggered prostaglandin release to counteract intraoperative miosis.
Achieving sustained pupillary enlargement is necessary to provide adequate visualization of posterior and intraocular structures, permit safe anterior capsulorhexis and lens manipulation, and minimize complications such as mechanical iris trauma or capsular rupture.
- nih.gov
Mydriasis during ocular surgery refers to the pharmacologically induced and maintained dilation of the pupil within the ophthalmic system during intraocular procedures, most notably cataract extraction and intraocular lens replacement
- nih.gov
Mydriasis during ocular surgery refers to the pharmacologically induced and maintained dilation of the pupil within the ophthalmic system during intraocular procedures, most notably cataract extraction and intraocular lens replacement Achieving sustained pupillary enlargement is necessary to provide adequate visualization of posterior and intraocular structures, permit safe anterior capsulorhexis and lens manipulation, and minimize complications such as mechanical iris trauma or capsular rupture
- fda.gov
This clinical state involves stimulating the iris dilator muscle, inhibiting the pupillary sphincter muscle, or blunting surgically triggered prostaglandin release to counteract intraoperative miosis
- medpagetoday.com
This clinical state involves stimulating the iris dilator muscle, inhibiting the pupillary sphincter muscle, or blunting surgically triggered prostaglandin release to counteract intraoperative miosis
- ophthalmologybreakingnews.com
This clinical state involves stimulating the iris dilator muscle, inhibiting the pupillary sphincter muscle, or blunting surgically triggered prostaglandin release to counteract intraoperative miosis
- nih.gov
Achieving sustained pupillary enlargement is necessary to provide adequate visualization of posterior and intraocular structures, permit safe anterior capsulorhexis and lens manipulation, and minimize complications such as mechanical iris trauma or capsular rupture
- aao.org
Achieving sustained pupillary enlargement is necessary to provide adequate visualization of posterior and intraocular structures, permit safe anterior capsulorhexis and lens manipulation, and minimize complications such as mechanical iris trauma or capsular rupture
Personalize your experience
Follow Mydriasis during ocular surgery and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.